ABSTRACT
The available data on the effectiveness of therapeutic hypothermia in different patient groups are heterogeneous. Although the benefits have been proven for some collectives, recommendations for the use of hypothermia treatment in other groups are based on less robust data and conclusions by analogy. This article gives a review of the current evidence of temperature management in all age groups and based on this state of knowledge, recommends active temperature management with the primary aim of strict normothermia (36-36.5 °C) for 72 hours after cardiopulmonary arrest or severe traumatic brain injury for children beyond the neonatal period.
Subject(s)
Body Temperature , Brain Injuries, Traumatic/therapy , Heart Arrest/therapy , Hypothermia, Induced/methods , Adolescent , Aging , Child , Child, Preschool , Critical Care/standards , Humans , InfantABSTRACT
Respiratory viruses are an important yet underestimated cause of infectious morbidity and mortality in immunocompromised children and adolescents. Here, we report the occurrence of fatal lower respiratory tract disease associated with human metapneumovirus (HMPV) infection in a 10-year-old girl with chronic graft-versus-host disease following allogeneic hematopoietic stem cell transplantation (HSCT) for secondary chronic myeloid leukemia. Symptoms occurred 8 months after HSCT while on immunosuppression with 0.2 mg/kg/day of prednisone, and presented as dry cough, bilateral pneumonitis, and progressive respiratory distress. Non-invasive and invasive microbiological investigations revealed HMPV type B as the sole pathogen. Histopathological findings showed interstitial and intra-alveolar pneumonitis with profound alveolar cell damage. The patient was treated with intravenous and oral ribavirin and polyvalent immunoglobulins, but ultimately died from respiratory failure. The case reflects the potentially fatal impact of infections by respiratory viruses in immunocompromised patients and the need for effective approaches to their prevention and treatment.
Subject(s)
Hematopoietic Stem Cell Transplantation/adverse effects , Metapneumovirus/isolation & purification , Paramyxoviridae Infections/virology , Respiratory Tract Infections/virology , Child , Fatal Outcome , Female , Graft vs Host Disease/complications , Humans , Immunocompromised Host , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/therapy , Paramyxoviridae Infections/complications , Paramyxoviridae Infections/diagnosis , Paramyxoviridae Infections/pathology , Respiratory Tract Infections/complications , Respiratory Tract Infections/diagnosis , Respiratory Tract Infections/pathology , Transplantation, Homologous/adverse effectsABSTRACT
OBJECTIVE: To identify and summarize the requirements of an optimized CPOE application for pediatric intensive care. METHODS: We analyzed the medication process and its documentation in the pediatric and neonatal intensive care units (PICU/NICU) of two university hospitals using workflow analysis techniques, with the aim of implementing computer-supported physician order entry (CPOE). RESULTS: In both PICU/NICU, we identified similar processes that differed considerably from adult medication routine. For example, both PICU/NICU prepare IV pump syringes on the ward, but receive individualized ready-to-use mixed IV bags for each patient from the hospital pharmacy on the basis of a daily order. For drug dose calculation, both PICU/NICU employ electronic calculation tools that are either incorporated within the CPOE system, or are external modules invoked via interface. CONCLUSION: On the basis of this analysis, we provide suggestions to optimize CPOE applications for use in the pediatric and neonatal intensive care unit in the form of three catalogues of desiderata for drug order entry support.
ABSTRACT
In this retrospective observational study covering 1998 to 2008, 32 patients (mean age: 7.50 years) were identified that had 35 episodes of candidaemia (0.47 cases/1000 hospital discharges). Cancer/allogeneic haematopoietic stem cell transplantation (43%) and congenital malformations/syndromes (21%) were the predominant underlying conditions. Central venous catheterization (90%), a history of antibacterial therapy (69%) and previous bacteraemia (54%) were frequent comorbidities. Candida albicans (46%) was most common, followed by Candida parapsilosis (17%) and Candida glabrata (14%). Resistance was infrequent and limited to non-albicans Candida spp. The 30-day and 100-day mortality rates were 11.4%.
Subject(s)
Candida/classification , Candida/isolation & purification , Candidemia/epidemiology , Adolescent , Candida/drug effects , Candidemia/microbiology , Candidemia/mortality , Child , Child, Preschool , Drug Resistance, Fungal , Europe/epidemiology , Female , Hospitals, Pediatric , Hospitals, University , Humans , Immunocompromised Host , Infant , Infant, Newborn , Male , Retrospective Studies , Risk Factors , Survival Analysis , Young AdultABSTRACT
OBJECTIVE: Different surgical approaches have been used to repair complete atrioventricular septal defects (AVSD). Regurgitant atrioventricular valves (AV-valves) are common after surgery. We compared different surgical techniques with respect to long-term postoperative AV-valve regurgitation. METHODS: In 69 patients with complete AVSD, three different surgical techniques were applied: Single-patch, two-patch, and modified techniques. The left-sided AV-valve cleft was surgically closed in all patients. RESULTS: A comparison of the results of the different techniques showed no difference in the degree of AV-valve regurgitation on either the right or the left side. The average degree was mild on both sides. Only one patient needed reoperation for severe left-sided AV-valve regurgitation. CONCLUSION: The different surgical techniques used for the correction of AVSD do not have a major bearing on the degree of AV-valve regurgitation.
Subject(s)
Cardiac Surgical Procedures , Heart Septal Defects/surgery , Mitral Valve Insufficiency/etiology , Postoperative Complications , Tricuspid Valve Insufficiency/etiology , Adolescent , Adult , Cardiac Output, Low , Cardiac Surgical Procedures/methods , Child , Child, Preschool , Down Syndrome/complications , Female , Heart Defects, Congenital , Humans , Infant , Male , Mitral Valve Insufficiency/surgery , Postoperative Complications/surgery , Reoperation , Retrospective Studies , Tricuspid Valve Insufficiency/surgeryABSTRACT
We present the case of a 10-year-old girl with cardiomyopathy who received a heart transplant. Due to organ rejection, the dosage of immunosuppressive agents was increased postoperatively. The patient complained of intermittent headaches in the following days and developed a haemorrhagic necrosis of the left thalamus. A week later, an oral dose of cyclosporin A was accidentally given intravenously, and 2 weeks later a recurrent subarachnoid haemorrhage of unknown origin was diagnosed. The clinical course was then characterised by progressive deterioration resulting in coma, fluctuating brain stem symptoms and the development of a massive cerebral oedema with subsequent brain death. A coroner's autopsy was instigated to investigate a claim of medical misadventure. Neuropathological investigations found a focal infiltration of fungal hyphae in the left posterior cerebral artery resulting in necrosis of the vascular wall and thus explaining the source of the recurrent subarachnoid haemorrhage which eventually resulted in the girl's death. Medical misadventure due to the administration of cyclosporin was not directly responsible for the death of this patient. This case illustrates that it is of paramount importance to copiously sample and investigate the basal cerebral arteries in cases of subarachnoid haemorrhage of unknown origin, in particular in a medico-legal context.
